The Human Tumor Atlas Network charts the roadmap for advancing spatial omics

Moving from mandate to mission: Community outreach and engagement at NCI-designated cancer centers
“COE is broken.”

Art exhibit at University of Miami Sylvester bridges North and South America

Don’t confirm RFK Jr. for HHS, 77 Nobel laureates urge the Senate

BSA approves four new, five reissue concepts

In Brief

VCU awarded $9M from NCI to establish Cancer Control Equity Research Center

Stephen Baylin and Andrew Feinberg, of Johns Hopkins, win Technion’s Harvey Prize

MD Anderson’s Lauren Averett Byers receives TAMEST O’Donnell Award

UCLA’s Christopher Seet receives $2.9M NCI grant to advance cell-based cancer treatments

UNM’s Julie In awarded $1.9M to study uranium exposure on intestinal lining

Wistar’s Nan Zhang and Noam Auslander receive $1.2M in biomedical research grants from V Foundation

Drugs & Targets

FDA approves durvalumab for LS-SCLC

MD Anderson, AmMax Bio announce agreements to develop immunotherapy for MRD-positive cancers

PolyPid announces collaboration with ImmunoGenesis in solid tumors

Dewpoint Therapeutics and ConcertAI form drug development partnership

FDA grants accelerated approval to zenocutuzumab-zbco for NSCLC and pancreatic adenocarcinoma

Merus and Partner Therapeutics announce license agreement for the U.S. commercialization of zenocutuzumab in NRG1 fusion-positive cancer

In The Clinic

Menin inhibitors emerge as new treatment for advanced AML

Kaklamani: The San Antonio Breast Cancer Symposium will focus on deescalating treatment while maintaining outcomes

A clinic at Fred Hutch addresses sexual health needs of patients with breast cancer
Data indicate low adherence to ASCO guideline

How we improved the treatment of Hodgkin lymphoma

A study measures the long-term downside of prostate cancer screening
A paper in JAMA Oncology focuses on the harms of overscreening, overdiagnosis, and overtreatment

Latest Issue

NEWS ALERTS

Stay up to date on the latest news in oncology by joining our mailing list.

UPCOMING EVENTS

Feb 2025

Mar 2025

Conversations with The Cancer Letter

Brian Druker steps down as CEO of OHSU Knight Cancer Center

2024 Harry Hynes Award winner Judith Hopkins on being a doctor in 1977, mentorship, and the benefits of community practice

Iowa’s Mark Burkard sees a role for data science in bringing clinical trials to rural clinics
The state has the second highest (and rising) cancer rates in the U.S.

Undergrad intern at MSK poses a profound question: What if Henrietta Lacks had a Black doctor?

Contributors

Casey Walsh, PhD, LICSW

Naoto T. Ueno, MD, PhD

Taras Ivanykovych

Samyukta Mullangi, MD, MBA

The Human Tumor Atlas Network charts the roadmap for advancing spatial omics

Moving from mandate to mission: Community outreach and engagement at NCI-designated cancer centers
“COE is broken.”

Art exhibit at University of Miami Sylvester bridges North and South America

Don’t confirm RFK Jr. for HHS, 77 Nobel laureates urge the Senate

BSA approves four new, five reissue concepts

VCU awarded $9M from NCI to establish Cancer Control Equity Research Center

Stephen Baylin and Andrew Feinberg, of Johns Hopkins, win Technion’s Harvey Prize

MD Anderson’s Lauren Averett Byers receives TAMEST O’Donnell Award

UCLA’s Christopher Seet receives $2.9M NCI grant to advance cell-based cancer treatments

UNM’s Julie In awarded $1.9M to study uranium exposure on intestinal lining

Wistar’s Nan Zhang and Noam Auslander receive $1.2M in biomedical research grants from V Foundation

FDA approves durvalumab for LS-SCLC

MD Anderson, AmMax Bio announce agreements to develop immunotherapy for MRD-positive cancers

PolyPid announces collaboration with ImmunoGenesis in solid tumors

Dewpoint Therapeutics and ConcertAI form drug development partnership

FDA grants accelerated approval to zenocutuzumab-zbco for NSCLC and pancreatic adenocarcinoma

Merus and Partner Therapeutics announce license agreement for the U.S. commercialization of zenocutuzumab in NRG1 fusion-positive cancer

Menin inhibitors emerge as new treatment for advanced AML

Kaklamani: The San Antonio Breast Cancer Symposium will focus on deescalating treatment while maintaining outcomes

A clinic at Fred Hutch addresses sexual health needs of patients with breast cancer
Data indicate low adherence to ASCO guideline

How we improved the treatment of Hodgkin lymphoma

A study measures the long-term downside of prostate cancer screening
A paper in JAMA Oncology focuses on the harms of overscreening, overdiagnosis, and overtreatment

Brian Druker steps down as CEO of OHSU Knight Cancer Center

2024 Harry Hynes Award winner Judith Hopkins on being a doctor in 1977, mentorship, and the benefits of community practice

Iowa’s Mark Burkard sees a role for data science in bringing clinical trials to rural clinics
The state has the second highest (and rising) cancer rates in the U.S.

Undergrad intern at MSK poses a profound question: What if Henrietta Lacks had a Black doctor?

Casey Walsh, PhD, LICSW

Naoto T. Ueno, MD, PhD

Taras Ivanykovych

Samyukta Mullangi, MD, MBA

Never miss an issue!

Login

The Human Tumor Atlas Network charts the roadmap for advancing spatial omics

Brian Druker steps down as CEO of OHSU Knight Cancer Center

2024 Harry Hynes Award winner Judith Hopkins on being a doctor in 1977, mentorship, and the benefits of community practice

Iowa’s Mark Burkard sees a role for data science in bringing clinical trials to rural clinicsThe state has the second highest (and rising) cancer rates in the U.S.

Undergrad intern at MSK poses a profound question: What if Henrietta Lacks had a Black doctor?

Never miss an issue!

Login

Iowa’s Mark Burkard sees a role for data science in bringing clinical trials to rural clinics
The state has the second highest (and rising) cancer rates in the U.S.